Atombeat and BioDuro have announced a strategic partnership to launch an AI-powered platform aimed at accelerating peptide drug discovery.

Regeneron has received an US Food and Drug Administration (FDA) rejection for a new blood cancer therapy and expects separate regulatory delays for blockbuster ophthalmology drug Eylea HD due to ...

Computational chemistry combined with AI technologies has become a powerful tool for assessing small molecule properties, ...

The beginning of August marks the latest deadline for US president Donald Trump’s “liberation day” tariff policy. This era of ...

India and the United Kingdom recently signed a Comprehensive Economic and Trade Agreement (CETA), but could it solve the ...

Thermo Fisher shows signs of post-COVID recovery, but modest growth, valuation risks, and macro pressures warrant caution.

Local pharma stocks were rocky on Friday after President Donald Trump directed major drugmakers to reduce the cost of their ...

Why pharma companies' "price transparency" reports paint a murky picture of how much Americans spend on prescription drugs.

Minister Tengku Zafrul Aziz says 100,000 workers may lose their jobs if electrical and electronic goods cannot be exported to ...

President Donald Trump's warnings about pharmaceutical tariffs have triggered a wave of manufacturing commitments from major ...

Evidence-based medicine "Boy Wonder" Dr. Vinay Prasad was fired as CBER Director after less than three months on the job.

After decades of limited progress—owing to the difficulty of treating the disease and resultant market risk—glioblastoma ...